JP2024516172A5 - - Google Patents
Info
- Publication number
- JP2024516172A5 JP2024516172A5 JP2023564582A JP2023564582A JP2024516172A5 JP 2024516172 A5 JP2024516172 A5 JP 2024516172A5 JP 2023564582 A JP2023564582 A JP 2023564582A JP 2023564582 A JP2023564582 A JP 2023564582A JP 2024516172 A5 JP2024516172 A5 JP 2024516172A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- subject
- dose
- mlpscs
- ards
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021901214A AU2021901214A0 (en) | 2021-04-23 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
| AU2021901214 | 2021-04-23 | ||
| AU2021902180 | 2021-07-15 | ||
| AU2021902180A AU2021902180A0 (en) | 2021-07-15 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
| AU2022900260 | 2022-02-09 | ||
| AU2022900260A AU2022900260A0 (en) | 2022-02-09 | Method for treating acute respiratory distress syndrome (ARDS) in specific patients using mesenchymal lineage precursor or stem cells | |
| AU2022900372 | 2022-02-18 | ||
| AU2022900372A AU2022900372A0 (en) | 2022-02-18 | Method for treating acute respiratory distress syndrome (ARDS) using mesenchymal lineage precursor or stem cells | |
| PCT/IB2022/053763 WO2022224207A1 (en) | 2021-04-23 | 2022-04-22 | Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precursor or stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516172A JP2024516172A (ja) | 2024-04-12 |
| JP2024516172A5 true JP2024516172A5 (https=) | 2025-05-01 |
Family
ID=81585202
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564582A Pending JP2024516172A (ja) | 2021-04-23 | 2022-04-22 | 間葉系前駆体又は幹細胞を使用する急性呼吸窮迫症候群（ａｒｄｓ）を治療するための方法 |
| JP2023564584A Pending JP2024516173A (ja) | 2021-04-23 | 2022-04-22 | 間葉系前駆体又は幹細胞を使用する特定の患者における急性呼吸窮迫症候群（ａｒｄｓ）を治療するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564584A Pending JP2024516173A (ja) | 2021-04-23 | 2022-04-22 | 間葉系前駆体又は幹細胞を使用する特定の患者における急性呼吸窮迫症候群（ａｒｄｓ）を治療するための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240207323A1 (https=) |
| EP (2) | EP4326294A1 (https=) |
| JP (2) | JP2024516172A (https=) |
| KR (2) | KR20240001172A (https=) |
| AU (2) | AU2022261504A1 (https=) |
| BR (2) | BR112023021840A2 (https=) |
| CA (2) | CA3216129A1 (https=) |
| WO (2) | WO2022224206A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120087868A1 (en) | 2010-10-08 | 2012-04-12 | Gabriele Todd | Nanoparticle-loaded cells |
| SG11202004680UA (en) | 2017-11-22 | 2020-06-29 | Mesoblast Int Sarl | Cellular compositions and methods of treatment i |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US6251295B1 (en) | 1998-01-08 | 2001-06-26 | Nexell Therapeutics Inc. | Method for recirculation washing of blood cells |
| BR112021024310A2 (pt) * | 2019-06-05 | 2022-02-15 | Univ Emory | Peptidomiméticos para o tratamento de infecções por coronavírus e picornavírus |
-
2022
- 2022-04-22 BR BR112023021840A patent/BR112023021840A2/pt unknown
- 2022-04-22 AU AU2022261504A patent/AU2022261504A1/en active Pending
- 2022-04-22 JP JP2023564582A patent/JP2024516172A/ja active Pending
- 2022-04-22 US US18/556,845 patent/US20240207323A1/en active Pending
- 2022-04-22 WO PCT/IB2022/053762 patent/WO2022224206A1/en not_active Ceased
- 2022-04-22 CA CA3216129A patent/CA3216129A1/en active Pending
- 2022-04-22 AU AU2022260822A patent/AU2022260822A1/en active Pending
- 2022-04-22 BR BR112023021825A patent/BR112023021825A2/pt unknown
- 2022-04-22 EP EP22721854.2A patent/EP4326294A1/en active Pending
- 2022-04-22 CA CA3216121A patent/CA3216121A1/en active Pending
- 2022-04-22 US US18/556,827 patent/US20240197787A1/en active Pending
- 2022-04-22 EP EP22724876.2A patent/EP4326295A1/en active Pending
- 2022-04-22 JP JP2023564584A patent/JP2024516173A/ja active Pending
- 2022-04-22 KR KR1020237039592A patent/KR20240001172A/ko active Pending
- 2022-04-22 KR KR1020237039593A patent/KR20240001173A/ko active Pending
- 2022-04-22 WO PCT/IB2022/053763 patent/WO2022224207A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ackermann et al. | Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow | |
| JP2024516172A5 (https=) | ||
| JP2023520233A5 (https=) | ||
| Cepkova et al. | Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome | |
| Ziemka-Nalecz et al. | Insights into the neuroinflammatory responses after neonatal hypoxia-ischemia | |
| Liu et al. | Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study | |
| Sawa et al. | Attenuation of cardiopulmonary bypass–derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations | |
| Mao et al. | Intravenous delivery of bone marrow-derived endothelial progenitor cells improves survival and attenuates lipopolysaccharide-induced lung injury in rats | |
| Blumenthal et al. | Ropivacaine decreases inflammation in experimental endotoxin-induced lung injury | |
| Hirschl et al. | Severe myocardial dysfunction during extracorporeal membrane oxygenation | |
| Hristov et al. | Adult progenitor cells in vascular remodeling during atherosclerosis. | |
| JP2018184448A5 (https=) | ||
| JP2012510521A5 (https=) | ||
| JP2021512903A5 (https=) | ||
| Babajani et al. | Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation | |
| Leibel et al. | Endogenous and exogenous stem/progenitor cells in the lung and their role in the pathogenesis and treatment of pediatric lung disease | |
| JP2024516173A5 (https=) | ||
| JP2023513847A5 (https=) | ||
| Wang et al. | Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study | |
| JP2025186248A5 (https=) | ||
| Shazley et al. | A COVID-positive 52-year-old man presented with venous thromboembolism and disseminated intravascular coagulation following Johnson & Johnson vaccination: a case-study | |
| Ma et al. | Low-dose post-transplant cyclophosphamide with G-CSF/ATG based haploidentical protocol provides favorable outcomes for SAA patients | |
| CN116406277A (zh) | 治疗急性呼吸道炎症病症和细胞因子风暴综合征的方法 | |
| Yewei et al. | Study of the mechanism of pulmonary protection strategy on pulmonary injury with deep hypothermia low flow. | |
| Nova-Lamperti et al. | Vascular Regeneration by Endothelial Progenitor Cells |